| |
Latest 10 SEC filings (by transaction date) for TRVI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 16/24 | Feb 15/24 | Galletta Christopher | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 28,500 | |
Feb 16/24 | Feb 15/24 | Simon Farrell | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Feb 16/24 | Feb 15/24 | Clark David J | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Feb 16/24 | Feb 15/24 | Good Jennifer L | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 630,000 | |
Feb 16/24 | Feb 15/24 | Sciascia Thomas | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Feb 16/24 | Feb 15/24 | Delfini Lisa | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Oct 12/23 | Oct 11/23 | Delfini Lisa | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,292 | |
Oct 12/23 | Oct 11/23 | Delfini Lisa | Direct Ownership | Common Stock | S - Open market or private sale | -785 | $2.02 |
Oct 12/23 | Oct 11/23 | Delfini Lisa | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,292 | $0.511 |
Sep 13/23 | Sep 11/23 | Delfini Lisa | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,291 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for TRVI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 16/24 | Feb 15/24 | Galletta Christopher | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 28,500 | |
Feb 16/24 | Feb 15/24 | Simon Farrell | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Feb 16/24 | Feb 15/24 | Clark David J | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Feb 16/24 | Feb 15/24 | Good Jennifer L | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 630,000 | |
Feb 16/24 | Feb 15/24 | Sciascia Thomas | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Feb 16/24 | Feb 15/24 | Delfini Lisa | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 175,000 | |
Oct 12/23 | Oct 11/23 | Delfini Lisa | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,292 | |
Oct 12/23 | Oct 11/23 | Delfini Lisa | Direct Ownership | Common Stock | S - Open market or private sale | -785 | $2.02 |
Oct 12/23 | Oct 11/23 | Delfini Lisa | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,292 | $0.511 |
Sep 13/23 | Sep 11/23 | Delfini Lisa | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -2,291 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |